Genomic Health Inc. (GHDX) Drops 6% on January 15

Equities Staff |

Genomic Health Inc. (GHDX) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 6% to $29.30, a loss of $-1.87 per share. Starting at an opening price of $30.20 a share, the stock traded between $29.12 and $30.43 over the course of the trading day. Volume was 193,694 shares over 2,961 trades, against an average daily volume of 266,629 shares and a total float of 32.54 million.

The losses send Genomic Health Inc. down to a market cap of $953.49 million. In the last year, Genomic Health Inc. has traded between $35.79 and $20.05, and its 50-day SMA is currently $30.19 and 200-day SMA is $27.16.

Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early stage cancer.

Genomic Health Inc. is based out of Redwood City, CA and has some 752 employees. Its CEO is Kimberly J. Popovits.

For a complete fundamental analysis analysis of Genomic Health Inc., check out’s Stock Valuation Analysis report for GHDX. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Inception Mining Inc

Inception Mining Inc a mining exploration stage company engaged in the acquisition, exploration, and development of mineral properties, for gold from owned mining properties.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.